Ulcus Marmoratus (Marmorated Ulcer) - Symptoms, Causes, Treatment & Prevention

```html

Overview

Ulcus marmoratus, commonly called a marmorated ulcer, is a rare form of chronic gastric or duodenal ulcer that displays a characteristic mottled (marble‑like) appearance on endoscopy. The term comes from the Latin marmoratus meaning “marbled.” Unlike typical peptic ulcers, which are usually shallow and solitary, the marmorated ulcer has multiple intertwined erosions with gray‑white fibrotic bands that give it a “marble” pattern.

Although exact prevalence data are limited because the condition is under‑reported, epidemiologic surveys suggest that it accounts for < 0.5 % of all peptic ulcer disease (PUD) cases in tertiary gastroenterology centers. It tends to affect adults between 40 and 70 years of age, with a slight male predominance (about 60 % of reported cases).

The condition is most often identified during endoscopic evaluation for dyspepsia, chronic upper‑abdominal pain, or complications such as bleeding. Early recognition is important because the healing pattern differs from standard ulcers, and some patients may require longer or more intensive therapy.

Symptoms

Symptoms overlap heavily with those of common peptic ulcers, but the chronic nature of the disease can lead to a broader spectrum of complaints.

• Epigastric pain – burning or gnawing pain 1–3 hours after meals; may improve with antacids.
• Post‑prandial fullness – feeling overly full after a small amount of food.
• Early satiety – inability to finish a normal meal.
• Nausea or vomiting – occasional, especially after large meals.
• Weight loss – usually modest (5–10 % of body weight) due to reduced intake.
• Upper‑GI bleeding – melena, hematemesis or “coffee‑ground” vomitus; may be intermittent.
• Iron‑deficiency anemia – fatigue, pallor, or shortness of breath from chronic blood loss.
• Odynophagia (painful swallowing) – less common, occurs when ulcer extends into the esophagus.
• Recurrent halitosis – foul breath from bacterial overgrowth in the ulcer crater.
• Unexplained dyspepsia – bloating, belching, or a vague sense of discomfort.

Causes and Risk Factors

Ulcus marmoratus is thought to result from the same pathogenic mechanisms that cause ordinary peptic ulcers, but with additional factors that promote the characteristic fibrotic “marbling.”

Primary causes

• Helicobacter pylori infection – the most common bacterial trigger (≈ 70 % of cases). The organism damages the gastric mucosa and stimulates acid secretion.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – especially chronic use of ibuprofen, naproxen, diclofenac, or selective COX‑2 inhibitors.
• Excess gastric acid production – often due to hypersecretory states such as Zollinger‑Ellison syndrome.

Risk factors that predispose to a “marmorated” healing pattern

• Chronic ischemia – atherosclerotic disease of the gastric arterial supply can impair healing and promote fibrosis.
• Smoking – nicotine reduces mucosal blood flow and impairs prostaglandin synthesis.
• Alcohol misuse – irritates the mucosa and increases acid output.
• Genetic predisposition – polymorphisms in cytokine genes (e.g., IL‑1β) that augment inflammatory response.
• Concurrent use of steroids or anticoagulants – heighten the risk of bleeding and delay ulcer repair.

Who is most at risk?

• Adults aged 40–70, especially males.
• Patients with a history of chronic NSAID use (≥ 3 months).
• Individuals positive for H. pylori who have not undergone eradication therapy.
• Smokers and heavy alcohol consumers.
• Patients with comorbid cardiovascular disease, diabetes, or chronic kidney disease that compromise microvascular perfusion.

Diagnosis

Because the clinical picture mirrors that of typical peptic ulcers, a high index of suspicion and endoscopic evaluation are essential.

Diagnostic steps

1. History and physical exam – focus on pain pattern, medication use, and risk factors.
2. Laboratory tests
   • Complete blood count (CBC) – to detect anemia.
   • Serum iron studies, ferritin – evaluate chronic blood loss.
   • Urea breath test, stool antigen, or gastric biopsy – to detect H. pylori.
3. Upper gastrointestinal endoscopy (esophagogastroduodenoscopy, EGD)
   • Direct visualization of the marbled ulcer pattern – gray‑white fibrotic streaks interlaced with active erosions.
   • Biopsy of the ulcer edge and base – rules out malignancy, confirms H. pylori, and assesses for Helicobacter‑associated gastritis.
4. Imaging (when complications are suspected)
   • CT angiography – evaluates for perforation or vascular involvement.
   • Upper GI series with barium – can demonstrate ulcer crater and possible fistula.

According to the American College of Gastroenterology, endoscopic findings of a “marbled” ulcer are considered diagnostic when combined with histopathology showing chronic inflammation, fibrosis, and absent malignant cells (CAG Guidelines, 2023).

Treatment Options

Management combines eradication of the underlying cause, acid suppression, mucosal protection, and, when needed, endoscopic or surgical intervention.

Medication regimen

• Proton‑pump inhibitors (PPIs) – omeprazole 20 mg bid, esomeprazole 40 mg daily, or pantoprazole 40 mg daily for 8‑12 weeks. PPIs are the cornerstone because they promote healing of the fibrotic tissue.
• H. pylori eradication therapy – triple therapy (PPI + clarithromycin 500 mg bid + amoxicillin 1 g bid) for 14 days, or quadruple therapy (PPI + bismuth subcitrate + tetracycline + metronidazole) when resistance is suspected.
• Histamine‑2 receptor blockers (H2RAs) – can be added if PPI dose reduction is needed.
• Sucralfate – 1 g qid for the first 4 weeks; adheres to ulcer surface and protects it from acid.
• Cytoprotective agents – misoprostol 200 µg qid (avoid in pregnancy) to increase mucosal prostaglandins.
• Antibiotics (non‑H. pylori) – if secondary bacterial overgrowth is documented, a short course of metronidazole may be used.
• Adjuncts for high‑risk patients
  • Iron supplementation (IV preferred if malabsorption suspected) for anemia.
  • Vitamin B12 if pernicious anemia co‑exists.

Procedural interventions

• Endoscopic hemostasis – epinephrine injection, thermal coagulation, or clip placement for active bleeding.
• Endoscopic mucosal resection (EMR) – rare, reserved for ulcer bases with suspicious lesions.
• Surgical management – indicated for perforation, refractory bleeding, or obstruction. Options include laparoscopic oversewing of the ulcer or partial gastrectomy.

Lifestyle modifications

• Stop smoking – nicotine cessation improves mucosal blood flow within 2 weeks.
• Avoid NSAIDs; if required, use the lowest effective dose with a PPI protector.
• Limit alcohol to ≤ 1 drink/day for women, ≤ 2 drinks/day for men.
• Adopt a “peptic‑ulcer‑friendly” diet – low‑fat, low‑spice, avoid caffeine and carbonated beverages.
• Maintain a healthy weight (BMI 18.5–24.9) to reduce intra‑abdominal pressure.

Living with Ulcus Marmoratus (Marmorated Ulcer)

Because the condition can be chronic, patients benefit from a structured self‑care plan.

Daily management checklist

1. Medication adherence – take PPIs exactly as prescribed; use a pill organizer.
2. Food journal – record meals, timing of pain, and trigger foods; review weekly with a dietitian.
3. Hydration – aim for 1.5–2 L of water/day; avoid carbonated drinks.
4. Stress reduction – practice mindfulness, yoga, or short walks for at least 10 minutes daily.
5. Regular follow‑up – endoscopy repeat at 8–12 weeks to confirm healing; then as clinically indicated.
6. Screen for anemia – CBC every 3 months until hemoglobin stabilizes.

Support groups (both online and in‑person) for chronic ulcer disease can provide emotional backing and shared coping strategies.

Prevention

Most cases are preventable by addressing modifiable risk factors.

• Eradicate H. pylori when detected – a single‑course therapy reduces ulcer recurrence by up to 80 % (CDC, 2022).
• Use NSAIDs cautiously – limit duration, choose the lowest effective dose, and co‑prescribe a PPI.
• Quit smoking – counseling, nicotine‑replacement, or medications such as varenicline.
• Limit alcohol – seek help for dependence if needed.
• Regular health checks – especially for patients with cardiovascular disease or diabetes, which affect mucosal perfusion.

Complications

If left untreated or inadequately managed, a marmorated ulcer can lead to serious outcomes.

• Upper‑GI bleeding – may be massive, requiring transfusion or emergency endoscopy.
• Perforation – a hole in the stomach or duodenal wall leading to peritonitis; surgical emergency.
• Gastric outlet obstruction – scarring narrows the pyloric channel, causing vomiting and weight loss.
• Stricture formation – fibrotic bands may cause chronic dysphagia if the ulcer is near the antrum.
• Malignancy risk – chronic inflammation modestly raises the odds of gastric adenocarcinoma (approximately 1–2 % over 10 years); surveillance endoscopy is recommended for high‑risk patients.
• Chronic anemia – due to ongoing occult bleeding.

When to Seek Emergency Care

---

Sources: Mayo Clinic. “Peptic ulcer disease.” 2023; CDC. “Helicobacter pylori – Treatment Guidelines.” 2022; American College of Gastroenterology. “Guidelines for the Management of Peptic Ulcer Disease.” 2023; NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Ulcer Overview.” 2022; WHO. “Gastric Ulcer Fact Sheet.” 2021; Cleveland Clinic. “Managing NSAID‑Induced Ulcers.” 2024.

```